Tag: physical sciences
-
Celgene Adopting A.I. Drug Discovery Technology
Drug maker Celgene is gaining access to an artificial intelligence platform developed by Exscientia Ltd, to find treatment candidates for cancer and autoimmune disorders.
-
NIH Funds Natural Hearing Restoration Technology
An international group of universities and companies is designing a next-generation device to restore more natural hearing to people suffering from hearing loss.
-
Venture Funds, Mergers in A.I. Up Sharply in 2018
Start-up companies working in artificial intelligence scored sizeable increases in venture financing, and were highly prized acquisition targets in 2018, a new analysis shows.
-
Mobile Device Screens That Tap Back
Engineers in Germany designed screens for mobile phones and tablets that not only feel touch pressure, but can also return pulses or vibrations to users’ fingers.
-
NIH Funding Nanodrugs to Prevent Opioid Addiction
A drug that invokes the immune system to block addictive effects of opioid pain drugs and heroin is in early development at Washington University in St. Louis.
-
Microsoft, Biotech Partner on Gene, Cell Therapies
A biotechnology company in the U.K. and U.S. software maker Microsoft are collaborating on new processes to speed development of gene and cell therapies.
-
Foundation Studies Robotic Arm-Wrist Assist Device
A not-for-profit foundation is evaluating a robotic device to help people with spinal cord injuries regain use of their arm, wrist, and hand after a spinal cord injury.
-
Spin-Off Producing Commercial-Grade Graphene
A company based on university lab research in the U.K. says it’s producing graphene, a promising carbon-based material, in quality and scale for electronics.
-
Genomics, A.I. Calculate Immune Health
An international team designed a technique to gauge a person’s immune system age and health, by analyzing genomic and cellular indicators with machine-learning algorithms.
-
Trial Shows Engineered Plant Product Heals Wounds
A small-scale clinical trial shows synthetic human collagen derived from engineered tobacco plants promotes closure of lower-limb wounds, often difficult to heal.